In addition, miR-145 downregulates ADAM17 expression by binding to the 3’-UTR of ADAM17, which leads to activation of the ADAM17-EGFR-Akt-C/EBP-β feedback loop and induction of tumor invasion (76). Here, ADAM17 is linked to neoplasm.